Condensed Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Jun. 30, 2012	Jun. 30, 2011
Cash flows from operating activities
Net loss	$ (13,920,940)	$ (8,449,006)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	929,776	349,017
Bad Debt Provision	0	80,000
Inventory obsolescence	0	53,000
Amortization of intangible assets	745,385	310,415
Impairment and other equipment charges	0	219,313
Stock-based compensation	1,586,798	866,512
Equity in loss of investee company	197,618	0
Payment of interest with common stock	66,500	0
Amortization of discounts and debt issuance costs on notes payable	1,069,950	0
Changes in assets and liabilities
Accounts receivable	(308,941)	(19,813)
Inventories	(1,326,357)	(163,382)
Prepaids and other current assets	(130,986)	92,636
Refundable income taxes	(20,905)	(164,640)
Accounts payable	937,808	(48,960)
Accrued compensation and benefits	45,373	(159,277)
Accrued expenses	618,026	(59,385)
Deferred revenues	(213,173)	842,828
Net cash used in operating activities	(9,724,068)	(6,250,742)
Cash flows from investing activities
Expenditures for property and equipment	(1,647,450)	(1,750,044)
Acquisition of business, net of cash acquired	0	(225,922)
Investment in investee company	(3,281,507)	0
Net cash used in investing activities	(4,928,957)	(1,975,966)
Cash flows from financing activities
Proceeds from issuance of notes payable	2,465,000	1,300,000
Repayments of bank loans and notes payable	(3,243,184)	(450,126)
Notes payable issuance costs	(227,693)	0
Proceeds from issuance of debenture notes payable	0	517,168
Proceeds from issuance of Series A preferred stock	2,197,240	3,030,000
Proceeds from issuance of Common Stock	17,138,150	5,495,081
Common stock issuance costs	(1,810,598)	0
Proceeds from noncontrolling interest	3,083,062	0
Net cash provided by financing activities	19,601,977	9,892,123
Effect of exchange rate changes on cash and cash equivalents	(36,330)	9,545
Net increase in cash and cash equivalents	4,912,622	1,674,960
Cash and cash equivalents - beginning of period	2,910,595	1,235,635
Cash and cash equivalents - end of period	7,823,217	2,910,595
Cash paid for interest	278,610	188,895
Cash received for income tax credit	223,703	634,835
Supplemental non-cash investing and financing activities:
Conversion of debenture notes payable to common stock	1,184,250	0
Conversion of debenture notes payable to Series A preferred stock	0	524,678
Issuance of common stock for discounted notes receivable	2,187,330	3,529,644
Issuance of common stock as consideration for equity issuance costs	0	683,634
Issuance of warrants as consideration for equity issuance costs	1,024,726	0
Redemption of preferred stock with notes receivable - common stock	6,436,089	0
Conversion of cash settled RSUs to stock settled RSUs	$ 0	$ 315,833
Issuance of warrants for purchase of property and equipment	0	11,834